세계의 국소 지혈제 시장 보고서(2025년)
Topical Hemostat Global Market Report 2025
상품코드 : 1811051
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 국소 지혈제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 9.4%로 확대되어 78억 1,000만 달러로 성장할 것으로 예상됩니다. 이 예측기간의 성장은 세계 고령화 인구의 확대, 외래수술센터(ASC) 증가, 환자의 결과 중시, 접착제와 지혈제의 조합 사용 증가, 바이오 베이스 재료의 채용 확대에 의해 초래될 것으로 예측됩니다. 예상되는 주요 동향으로는 지혈 기술 혁신, 디지털 건강 솔루션 도입, 전달 시스템 개선, 조합 제품 창출, 지혈 관리에서 로봇 공학 활용 등이 있습니다.

수술 치료 증가는 향후 수년간 국소 지혈제 시장의 성장을 가속할 것으로 예측됩니다. 외과적 처치는 외과의사가 수술이나 특수한 기구를 이용해 실시하는 의료 개입이며, 상해, 질환, 신체 이상의 진단, 치료, 수복을 실시했습니다. 세계 인구의 급속한 고령화에 따라 이러한 치료의 빈도가 크게 상승하고 있으며, 생활의 질을 높이고 만성 상태를 관리하기 위해 수술 치료가 필요한 노화와 관련된 건강 문제의 발생률이 높아지고 있습니다. 국소 지혈제는 외과 의사가 수술 부위의 출혈을 신속하게 제어하고, 시인성을 향상시키고, 출혈량을 줄이고, 수술 후 합병증의 위험을 줄이기 위해 수술 중에 사용됩니다. 예를 들어 2023년 9월 미국의 비정부기구인 국제미용형성외과학회(ISAPS)는 성형외과의사가 2022년에 실시한 수술 건수는 2021년에 비해 11.2% 증가해 세계 1,490만 건 이상의 수술과 1,880만 건 이상의 비외과 수술이 실시됐습니다. 그 결과, 수술 건수 증가가 국소 지혈제 시장의 확대에 박차를 가하고 있습니다.

건강 관리 지출 증가는 국소 지혈제 시장의 향후 성장을 지원할 것으로 기대됩니다. 건강 관리 지출에는 지정된 기간 내에 의료 서비스, 치료 및 건강 관련 자원에 대한 지출 총액이 포함됩니다. 인구의 고령화에 따른 건강 관리 지출 증가는 의료 서비스, 장기 관리, 노화 관련 질환의 치료에 대한 수요 증가를 가져오고, 의료 제도에 대한 재정 부담을 증가시키고 있습니다. 이러한 지출 증가는 더 많은 수술적 개입을 가능하게 하고, 첨단 의료 기술의 채용을 촉진하고, 세계적인 건강 관리 접근을 개선함으로써, 국소 지혈제 수요를 증가시킵니다. 자금 증가로 병원은 특히 저침습 수술과 외래 수술을 위한 효율적인 출혈 제어 솔루션에 투자할 수 있습니다. 예를 들어 미국 전문가 단체인 미국 의사회에 따르면 미국 의료비는 2023년 7.5% 증가했고 4조 9,000억 달러(1인당 1만 4,570달러)에 이르렀으며 2022년 4.6% 증가에 비해 상당한 성장세를 보였습니다. 이 때문에 의료 지출 증가는 국소 지혈제 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

A topical hemostat is a specialized medical product applied directly to a bleeding area during surgery or trauma to quickly promote clotting and control bleeding. These agents act locally by forming a physical barrier, triggering the body's natural clotting processes, or providing a structure that supports platelet clumping and fibrin formation to stop blood flow.

The primary types of topical hemostats include fibrin, thrombin, cellulose, collagen, gelatin, adhesives, and others. Fibrin hemostats are biologically derived agents that replicate the final stages of the coagulation process by combining fibrinogen and thrombin to form a stable clot at the bleeding site. These products are distributed through channels such as direct sales, distributors, hospital pharmacies, and online platforms, and they find application in various surgeries including general, neurosurgery, vascular, and cardiovascular procedures. Key end users comprise hospitals, ambulatory surgical centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The topical hemostat market research report is one of a series of new reports from The Business Research Company that provides topical hemostat market statistics, including topical hemostat industry global market size, regional shares, competitors with a topical hemostat market share, detailed topical hemostat market segments, market trends and opportunities, and any further data you may need to thrive in the topical hemostat industry. This topical hemostat market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The topical hemostat market size has grown strongly in recent years. It will grow from $4.96 billion in 2024 to $5.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth during the historic period is driven by rising healthcare spending, a higher number of minimally invasive procedures, an increase in chronic disease cases, growing demand for surgical interventions, and greater interest in biodegradable products.

The topical hemostat market size is expected to see strong growth in the next few years. It will grow to $7.81 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. Growth in the forecast period is expected to result from the expanding global aging population, a rise in ambulatory surgical centers, increased emphasis on patient outcomes, growing use of adhesive-hemostat combinations, and wider adoption of bio-based materials. Key trends anticipated include innovations in hemostatic technologies, the incorporation of digital health solutions, improvements in delivery systems, the creation of combination products, and the use of robotics in managing hemostasis.

The increasing number of surgical procedures is anticipated to drive the growth of the topical hemostat market in the coming years. Surgical procedures involve medical interventions performed by surgeons using manual techniques and specialized instruments to diagnose, treat, or repair injuries, diseases, or bodily abnormalities. The frequency of these procedures is rising significantly as the global population ages rapidly, leading to a higher occurrence of age-related health issues that require surgical treatment to enhance quality of life and manage chronic conditions. Topical hemostats are utilized during surgeries to help surgeons quickly control bleeding at the surgical site, improve visibility, reduce blood loss, and lower the risk of postoperative complications. For example, in September 2023, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based non-governmental organization, reported that plastic surgeons performed 11.2% more procedures in 2022 compared to 2021, with over 14.9 million surgical and 18.8 million non-surgical procedures conducted worldwide. Consequently, the rising number of surgical procedures is fueling the expansion of the topical hemostat market.

Increasing healthcare expenditure is expected to support the growth of the topical hemostat market going forward. Healthcare expenditure encompasses the total spending on medical services, treatments, and health-related resources within a specified timeframe. The growth in healthcare spending, driven by an aging population, results in increased demand for medical services, long-term care, and treatments for age-related conditions, which collectively place greater financial strain on healthcare systems. This rise in expenditure boosts the demand for topical hemostats by enabling more surgical interventions, promoting the adoption of advanced medical technologies, and improving global healthcare access. Increased funding allows hospitals to invest in efficient bleeding control solutions, particularly for minimally invasive and outpatient surgeries. For instance, according to the American Medical Association, a US-based professional association, health spending in the U.S. increased by 7.5% in 2023, reaching $4.9 trillion or $14,570 per person, marking a significant rise compared to the 4.6% growth seen in 2022. Therefore, the escalating healthcare expenditure is driving the growth of the topical hemostat market.

Key players in the topical hemostat market are concentrating on developing innovative products such as hemostatic sealing patches to improve bleeding control during surgeries by offering faster, more effective, and targeted hemostasis at the wound site. A hemostatic sealing patch is a medical device made from materials like collagen or fibrin that rapidly stops bleeding by adhering to tissue and facilitating clot formation during surgery. For example, in November 2023, Ethicon, Inc., a US-based company specializing in surgical technologies, launched the ETHIZIA Hemostatic Sealing Patch, a new synthetic polymer-based adjunctive hemostat clinically shown to stop severe bleeding on internal organs quickly. In clinical trials, ETHIZIA halted bleeding within 30 seconds in 80% of patients, which is six times faster than leading fibrin sealant patches. The patch is uniquely designed to be effective on both sides and highly adaptable, allowing it to be trimmed, rolled, pulled apart, or customized for use in both open and minimally invasive surgeries. It dehydrates blood and speeds coagulation through a gelatin carrier infused with polyoxazoline polymer, forming a strong adhesive hydrogel that bonds firmly to tissue.

Major players in the topical hemostat market are Pfizer Inc., Johnson & Johnson, Medtronic Plc, Medline Industries, Becton Dickinson and Company, Stryker Corporation, Baxter International, Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Samyang Holdings, Integra LifeSciences, Medicom Group, B. Braun SE, Advanced Medical Solutions Group Plc, Axio Biosolutions, Marine Polymer Technologies Inc, Hangzhou Singclean Medical Products, Neo Modulus Medical Sci-Tech, Tricol Biomedical, HemCon Medical Technologies Inc., Hemostasis LLC, KATSAN Medical Devices, Zhejiang Perfectseal New Materials.

North America was the largest region in the topical hemostat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in topical hemostat report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the topical hemostat market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The topical hemostat market consists of sales of physical hemostats, active coagulation agents, synthetic and hemisynthetic agents, natural and plant-based agents, and chitosan-based dressings. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Topical Hemostat Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on topical hemostat market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for topical hemostat ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The topical hemostat market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Topical Hemostat Market Characteristics

3. Topical Hemostat Market Trends And Strategies

4. Topical Hemostat Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Topical Hemostat Growth Analysis And Strategic Analysis Framework

6. Topical Hemostat Market Segmentation

7. Topical Hemostat Market Regional And Country Analysis

8. Asia-Pacific Topical Hemostat Market

9. China Topical Hemostat Market

10. India Topical Hemostat Market

11. Japan Topical Hemostat Market

12. Australia Topical Hemostat Market

13. Indonesia Topical Hemostat Market

14. South Korea Topical Hemostat Market

15. Western Europe Topical Hemostat Market

16. UK Topical Hemostat Market

17. Germany Topical Hemostat Market

18. France Topical Hemostat Market

19. Italy Topical Hemostat Market

20. Spain Topical Hemostat Market

21. Eastern Europe Topical Hemostat Market

22. Russia Topical Hemostat Market

23. North America Topical Hemostat Market

24. USA Topical Hemostat Market

25. Canada Topical Hemostat Market

26. South America Topical Hemostat Market

27. Brazil Topical Hemostat Market

28. Middle East Topical Hemostat Market

29. Africa Topical Hemostat Market

30. Topical Hemostat Market Competitive Landscape And Company Profiles

31. Topical Hemostat Market Other Major And Innovative Companies

32. Global Topical Hemostat Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Topical Hemostat Market

34. Recent Developments In The Topical Hemostat Market

35. Topical Hemostat Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기